Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Study Objective. To describe the characteristics and clinical outcomes of hematopoietic stem cell transplant (HSCT) recipients who received adjunctive cytomegalovirus intravenous immune globulin (CMV‐IVIG) for probable or proven CMV disease. Design. Retrospective cohort study. Setting. Large, univer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacotherapy 2010-06, Vol.30 (6), p.554-561
Hauptverfasser:	Alexander, Bryan T., Hladnik, Lindsay M., Augustin, Kristan M., Casabar, Ed, McKinnon, Peggy S., Reichley, Richard M., Ritchie, David J., Westervelt, Peter, Dubberke, Erik R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - therapeutic use Adult Antiviral Agents - therapeutic use Biological and medical sciences CMV-IVIG Cytomegalovirus cytomegalovirus disease Cytomegalovirus Infections - drug therapy Cytomegalovirus Infections - mortality cytomegalovirus intravenous immune globulin Female hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation - methods Hematopoietic Stem Cell Transplantation - mortality Hematopoietic Stem Cell Transplantation - statistics & numerical data Humans Immunoglobulins - administration & dosage Immunoglobulins - therapeutic use Immunoglobulins, Intravenous - therapeutic use Infectious diseases Male Medical sciences Pharmacology. Drug treatments Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!